Safety and persistence of Ustekinumab in patients with Psoriatic Arthritis in BIOBADASER
14/08/2023
N. Busquets-Pérez1 , C. Sánchez-Piedra2 , P. Vela-Casasempere3 , M. FreireGonzalez4 , C. Bohórquez5 , L. Expósito6 , B. Magallon7 , F. Manero8 , J. Del Pino Montes9 , C. Diaz Torne10, R. Martin Domenech11, M. Pascual12, F. SánchezAlonso2
EULAR 2020
DOI: 10.1136/annrheumdis-2020-eular.3195
https://ard.bmj.com/content/79/Suppl_1/1672.2